Professor John G. Thomas, MS, PhD, HCLD

(High Complexity Laboratory Director) Global Microbiologist and International Educator

John Thomas

Professor Thomas is presently Director of the Biofilm Research Laboratory for Translational Studies in Medicine, Dentistry, and Industry at West Virginia University, Morgantown, WV, US and Senior Consultant to Clinical Microbiology , WVUH. He created the International Tri-University Biofilm Research Consortium in 2002 to further global investigations and education (www.hsc.wvu.edu/som/pathology/thomas), initially focusing on VAP and the MV ICU patient highlighting   the oral -systemic link

He  completed a six month Sabbatical at Cardiff University, School of Dental Medicine in 2008 and has travelled extensively, lecturing in 16 countries, four continents and to greater than 15,000 educators and public healthcare providers. He is co-organizer of the First Asia Pacific Biofilm Congress which is to be held in China, Spring 2011. He has published extensively on diverse microbial topics emphasizing oral biofilms and their importance in probiotic management, and their link to systemic diseases , chronic wounds, global antibiotic resistance  and recently the tumor –biofilm connection.

Dr. Thomas integrates four academic and educational positions at West Virginia University: School of Medicine, Pathology, School of Dentistry, Periodontology, School of Pharmacy, and Graduate School, Department of Microbiology and Cell Biology. He also holds teaching positions at Rutgers University and internationally is a Visiting Professor (Honorary) at Cardiff University, School of Dental Medicine as a Academic Visitor, National University of Singapore, School of Dentistry.

In 2008, Dr. Thomas was invited to join the Scientific Advisory Council, American Dental Association (ADA), and in 2007, he was given the highest achievement award for University Teaching at WVU, recognized by students. In 2009, Dr. Thomas was awarded the Student Research Development Award by the School of Dentistry, having received the award in 2006 and 1998

His translational research continues to focus on biofilms but has expanded to include VAP in the NICU,  chronic wounds , the use of probiotics, and biofilms as tumors via pre-clinical trials and engineered simulators for each ; Dr Thomas, as a co PI, recently received a $1.35 million NIH/Homeland Security  grant with Purdue University collaborators, to evaluate a rapid detection system for food borne pathogens and potential bio-terrorist modified organisms.     
Translational Research

Bio Diversity

Mission:

Originally, we were interested in the 3-linked arenas of clinical/translational research and their impact upon diagnostic microbiology, specifically, and healthcare, generally, with three branches: Biofilms, Antibiotic Resistance, and Clinical and Financial Outcomes.

Recently, we added the 4th topic of oral drivien systemic infectious diseases, focusing on the oral-lung (VAP) connection specifically and oral health, generally, with an international focus (Asia-Pacific and the UK).

Overview:

In the oral cavity, there are greater than 700 different microbial species; it is the most diverse microbial population in the host and diversity equals survival.  However, a select proportion will up-regulate from planktonic phenotype (PP) to a biofilm phenotype (PBF), attach to the gingival surface, periodontal pocket, or endodonic surface based on their stress response genes and ‘Quorum Sensing.’  Microorganisms actually have three phenotypes or potential Life Cycles...

Learn More

Newsletters

  • 2009 June; Vol. 2 No. 1

    The years 2007 and 2008 saw the most extensive and incredible travel journey for me, and my wife, Penny. During and after the Sabbatical at Cardiff University, Wales, UK, July through December, fall 2007, Penny and I travelled to 16 countries, four continents and greater than 130,000 miles. I will summarize Key Points of each from a personal, scientific and educational perspective

  • 2007 July; Vol. 1 No. 2

    2007 has been an incredible year for increased awareness of biofilms.  Everywhere one looks, from the “lay” literature to the scientific literature, new articles describe the impact of biofilms and chronic infections.  Below is a summary of the events that we were intimately involved with and emphasize the growing awareness of biofilms

    View More Newsletters